ZHOU, D., LIANG, J., XU, L., HE, F., ZHOU, Z., ZHANG, Y., & CHEN, M. (2016). Derived neutrophil to lymphocyte ratio predicts prognosis for patients with HBV-associated hepatocellular carcinoma following transarterial chemoembolization. Oncol Lett.
シカゴスタイル引用形ZHOU, DONGSHENG, JIANZHONG LIANG, LI XU, FENGYING HE, ZHONGGUO ZHOU, YAOJUN ZHANG, , MINSHAN CHEN. "Derived Neutrophil to Lymphocyte Ratio Predicts Prognosis for Patients With HBV-associated Hepatocellular Carcinoma Following Transarterial Chemoembolization." Oncol Lett 2016.
MLA引用形式ZHOU, DONGSHENG, et al. "Derived Neutrophil to Lymphocyte Ratio Predicts Prognosis for Patients With HBV-associated Hepatocellular Carcinoma Following Transarterial Chemoembolization." Oncol Lett 2016.